Skip to main content
TipRanks
Go Ultimate75% OFF

Corbus Pharmaceuticals (3371) Ownership - Who Owns Corbus Pharmaceuticals?

0 Followers

Corbus Pharmaceuticals (3371) Ownership Overview

  • 12.09% Insiders
  • 6.92% Mutual Funds
  • 63.38% Other Institutional Investors
  • 9.00% ETFs
  • 8.61% Public Companies and Individual Investors

The ownership structure of Corbus Pharmaceuticals (DE:3371) stock is a mix of institutional, retail, and individual investors. Approximately 79.30% of the company’s stock is owned by Institutional Investors, 12.09% is owned by Insiders, and 8.61% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 01, 2026Cormorant Asset Management, Llc$1,742,500
Aug 11, 2026Nishant C Saxena$25,012
Jun 02, 2026Nishant C Saxena$101,205
Mar 03, 2026Dominic Smethurst$50,544

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:3371 top shareholders
Holder# of SharesType% HoldingValue
Cormorant Asset Management, Llc1,919,971Insider9.32%5,800,232
Peter Kolchinsky1,914,788Institution9.29%5,784,575
BlackRock, Inc.1,749,919Institution8.49%5,286,505
Vanguard Index Funds741,885Institution3.60%2,241,235
Vanguard735,900Institution3.57%2,223,154
Ishares638,868Institution3.10%1,930,020
Fidelity Salem Street Trust205,319Institution1.00%620,269
Yuval Cohen157,316Insider0.76%475,252
Global X151,958Institution0.74%459,065
Fidelity Concord Street Trust128,430Institution0.62%387,987

Top Mutual Fund Holders

DE:3371 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds741,885Institution3.60%2,241,235
Fidelity Salem Street Trust205,319Institution1.00%620,269
Fidelity Concord Street Trust128,430Institution0.62%387,987
Vanguard Scottsdale Funds111,529Institution0.54%336,929
Dfa Investment Dimensions Group Inc73,194Institution0.36%221,119
Schwab Capital Trust59,702Institution0.29%180,360
Tiaa-cref Funds22,308Institution0.11%67,392
Goldman Sachs Trust21,356Institution0.10%64,516
T. Rowe Price Index Trust, Inc.15,083Institution0.07%45,566
Vanguard Institutional Index Funds11,420Institution0.06%34,500

FAQ

Who Owns Corbus Pharmaceuticals (DE:3371)?
According to the latest TipRanks data, approximately 79.30% of the company's stock is held by institutional investors, 12.09% is held by insiders, and 8.61% is held by public companies and individual investors.
What percentage of Corbus Pharmaceuticals (DE:3371) stock is held by institutional investors?
According to the latest TipRanks data, approximately 79.30% of Corbus Pharmaceuticals (DE:3371) stock is held by institutional investors: 6.92% by mutual funds, 9.00% by ETFs and 63.38% by other institutional investors.
What percentage of Corbus Pharmaceuticals (DE:3371) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.61% of Corbus Pharmaceuticals (DE:3371) stock is held by public companies and individual investors.
Who owns the most shares of Corbus Pharmaceuticals (DE:3371)?
Cormorant Asset Management, LLC owns the most shares of Corbus Pharmaceuticals (DE:3371).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.